Therapy Invest Information

Companies
FDA Grants Anixa Biosciences' Individual Patient IND for Second Dose of CAR-T Ovarian Cancer Therapy Jul 23, 2024
Pharmaceuticals
Innovative COPD Therapy Dupixent Gains Approval in the EU, Marking a First for Targeted Treatment Jul 4, 2024
Pharmaceuticals
FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment Jun 12, 2024
Pharmaceuticals
GENFIT Reaches Historic FDA Approval with Ipsen's Iqirvo® for Primary Biliary Cholangitis Jun 11, 2024
Companies
Eisai Submits LEQEMBI® (lecanemab-irmb) Biologics License Update to FDA for Early Alzheimer's Treatment – Biogen Stocks in Focus Jun 10, 2024
Companies
BioNTech Projects Ten Oncology Trials by End of 2024 Leading to First Launch in 2026 Mar 20, 2024
Companies
MindMed's Strategic Shift in 2024: Focusing on Anxiety Treatments and Halting LSD Microdosing for ADHD Jan 11, 2024
Analysis
StockNews.com Initiates Coverage on Lipocine (LPCN), Impacts of Institutional Trading Highlighted Nov 12, 2023
PharmAla Begins Groundbreaking Observational Trial for Real-World Efficacy of MDMA Therapy Nov 9, 2023
Pioneering Observational Trial on MDMA Treatment Kicks Off with PharmAla, Heroic Hearts, and University of Calgary Nov 9, 2023
PharmAla, University of Calgary, and Heroic Hearts Canada Launch Observational MDMA Efficacy Trial Nov 9, 2023